Paul Hastings, Sidley Austin, and Maples Group have advised Accelerant. Houlihan Lokey and Conyers Dill & Pearman have advised the Special Committee of Accelerant. Goodwin Procter,...
Accelerant Enters Into $4 Billion Take-Private Acquisition by Thoma Bravo
Obsidian Therapeutics and Galera Therapeutics Announce $350 Million Merger and Private Placement
Goodwin Procter LLP has advised Obsidian Therapeutics. Sidley Austin LLP has advised Galera Therapeutics. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the placement...
Brevo Completes Management-Led LBO with New Investment Consortium
Goodwin Procter has advised Brevo, its founder Armand Thiberge, and the management team. Kirkland & Ellis has advised a consortium consisting of Oakley Capital and General...
Stago Enters Exclusive Negotiations for Majority Stake Acquisition by ARCHIMED and La Caisse
Goodwin Procter has advised Stago, while Dechert has advised ARCHIMED. The Stago Group, a global leader in diagnostics and hemostasis, has entered into exclusive negotiations with...
Centerbridge Partners to Acquire MeridianLink in $2 Billion All-Cash Transaction
Kirkland & Ellis has advised Centerbridge Partners, and Goodwin Procter has advised MeridianLink. Skadden has advised Thoma Bravo, MeridianLink, Inc.’s largest shareholder. Paul Hastings LLP represented...
DoorDash Acquires SevenRooms in $1.2 Billion Deal
Weil, Gotshal & Manges has advised PSG; Goodwin has advised SevenRooms; A&O Shearman has advised DoorDash. PSG has finalized the sale of SevenRooms, a prominent New...
Merck’s $3.9 Billion Acquisition of SpringWorks Therapeutics
Sullivan & Cromwell advised Merck KGaA, Darmstadt, Germany, while Goodwin Procter advised SpringWorks Therapeutics on the transaction. Skadden advised Centerview Partners and Goldman Sachs & Co....
Novo Holdings’ Investment in Biocomposites
On the deal, Linklaters and Kirkland & Ellis advised Novo Holdings; Goodwin advised TA Associates. Novo Holdings, a holding and investment company responsible for managing the...
Bristol Myers Squibb’s $286 Million Acquisition of 2seventy bio
Covington & Burling advised Bristol Myers Squibb on the deal, and Goodwin Procter advised 2seventy bio. Bristol Myers Squibb (NYSE: BMY) (“BMS”) announced its merger agreement...
Helix Acquisition Corp. II’s US$949 Million Business Combination with BridgeBio Oncology Therapeutics
Goodwin Procter acted as legal counsel to BridgeBio Oncology Therapeutics, while White & Case acted as legal counsel to Helix Acquisition Corp. II on the transaction....
Jade Biosciences’ Merger with Aerovate Therapeutics
Gibson, Dunn & Crutcher advised Jade Biosciences on the transaction, and Cooley advised the placement agents; while Goodwin Procter advised Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc....
AVROBIO’s Merger with Tectonic Therapeutic
Leerink Partners is serving as exclusive financial advisor to Tectonic and Cooley LLP is serving as legal counsel to Tectonic. Leerink Partners and TD Cowen are...